Aarkstore.com announces, The Latest market research report is available inits vast collection:Zydus Cadila Healthcare Limited – Product Pipeline Review –2012More about this reportYou can also request for sample page of above mention reports email@example.comSummaryGlobal Markets Direct’s pharmaceuticals report, “Zydus Cadila Healthcare Limited -Product Pipeline Review - 2012” provides data on the Zydus Cadila HealthcareLimited’s research and development focus. The report includes information oncurrent developmental pipeline, complete with latest updates, and features ondiscontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Zydus Cadila Healthcare Limited’s corporate website, SECfilings, investor presentations and featured press releases, both from Zydus CadilaHealthcare Limited and industry-specific third party sources, put together by GlobalMarkets Direct’s team.Scope- Zydus Cadila Healthcare Limited - Brief Zydus Cadila Healthcare Limited overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Zydus Cadila Healthcare Limited human therapeuticdivision.
- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 6List of Figures 7Zydus Cadila Healthcare Limited Snapshot 8Zydus Cadila Healthcare Limited Overview 8Key Information 8Key Facts 8Zydus Cadila Healthcare Limited – Research and Development Overview 9Key Therapeutic Areas 9Zydus Cadila Healthcare Limited – Pipeline Review 12Pipeline Products by Stage of Development 12Pipeline Products – Monotherapy 13Zydus Cadila Healthcare Limited – Pipeline Products Glance 14Zydus Cadila Healthcare Limited – Late Stage Pipeline 14Registration Filed Products/Combination Treatment Modalities 14Phase III Products/Combination Treatment Modalities 15Zydus Cadila Healthcare Limited Clinical Stage Pipeline Products 16Phase II Products/Combination Treatment Modalities 16Phase I Products/Combination Treatment Modalities 17Zydus Cadila Healthcare Limited – Early Stage Pipeline Products 18Pre-Clinical Products/Combination Treatment Modalities 18Discovery Products/Combination Treatment Modalities 19Zydus Cadila Healthcare Limited – Drug Profiles 20Blonanserin 20Product Description 20Mechanism of Action 20R&D Progress 20Drug For Atherosclerotic Plaque 21Product Description 21Mechanism of Action 21R&D Progress 21
IFN-Beta-1b 22Product Description 22Mechanism of Action 22R&D Progress 22MAb 1 23Product Description 23Mechanism of Action 23R&D Progress 23MAb 3 24Product Description 24Mechanism of Action 24R&D Progress 24MAb 4 25Product Description 25Mechanism of Action 25R&D Progress 25List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview – 2012&PubId=&pagenum=1MacroGenics, Inc. – Product Pipeline Review – 2012TopoTarget A/S – Product Pipeline Review – 2012YM BioSciences Inc. – Product Pipeline Review – 2012
ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012Acucela Inc. – Product Pipeline Review – 2012Aldagen, Inc. – Product Pipeline Review – 2012Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585